HOW WE CAN HELP:
We offer support to patients with Osteoarthritis and Rheumatoid Arthritis implementing IV Nutritional Therapy and Therapeutic LPG Endermologie™.
This scientifically proven technology is applied along with other therapies such as: Trigger Point Therapy utilizing MSM and IV Nutrient Therapy. Our goal for you is to achieve a reduction in pain, stiffness and increase in range of motion, hand grip strength and overall function of the joints. Our accredited staff work as a team to promote health, wellness and prevention.
IV Nutritional Therapy infuses vitamins, minerals & nutrients to help you achieve your health goals. When custom therapy is chosen and applied, the nutrients are infused directly into the blood stream. This provides maximum effect, in comparison to oral administration, where the digestive tract compromises the absorption of the supplement and the effectiveness of the outcome.
Our focus is on your needs, health and well-being. Our registered nurse is certified in Fundamentals and Clinical Applications of IV Nutrient Therapies and is qualified to compound and administer our cocktails. They are tailored to your specific needs making our infusion therapy unique to each client.
We offer custom support for day to day management of symptoms focusing on calming down the inflammatory process by using nutrients such as curcumin, MSM (methylsulfonylmethane), vit. C and vit. B6. IV homeopathy such as devils claw, arnica, wild hops are incorporated to enhance the effect of our custom treatments.
RHEUMATOID ARTHRITIS (RA)
Unlike the pathophysiology of OA (Osteoarthritis) which is largely mechanical, RA is an autoimmune condition. It is characterized by inflammation and occurs usually in symmetrical parts of the body. The clinical manifestations are extremely variable and display exacerbation and remission. RA is accompanied by systemic features such as morning stiffness and fever. It is not entirely clear why immune diseases develop. The initial triggers of RA can include a combination of factors such as hormones, genetics, environmental factors, bacterial overgrowth in the digestive tract, increased gut permeability and retention of toxic metabolites. Once the initial immune response is triggered, cells of the immune system produce auto antibodies and inflammatory cytokines. Cytokines are a broad and loose category of small proteins that are important in cell signaling. They are released by cells and affect the behavior of other cells. Cytokines are crucial for fighting off infections and other immune responses. However, they become deregulated and pathological in inflammation, trauma and sepsis.
Pathophysiology of Rheumatoid Arthritis
The auto antibodies and inflammatory cytokines create an inflammation cascade resulting in the formation of pannus. Pannus is an abnormal layer of fibrovasula or granulation tissue and it invades and destroys cartilage and bone. Additional joint damage and systemic complications ensue resulting from a complex process of inflammatory mediators being released in the affect joint.
Labeled “the nation’s primary crippler” it occurs as a result of inflammation and weakening of the joint capsule and the cartilage lining the joints. It can be classed as either primary (idiopathic) meaning without discernable relation to another disease. It mainly presents in middle age or elderly individuals. Secondary OA may present at any age in a joint due to trauma, disease such as TB (tuberculosis), gout, rheumatoid arthritis or deformity such as congenital dislocation of the hip. OA is often asymptomatic but joint pain, decreased range of motion, crepitus (a crackling sensation when the joint is moved) and joint enlargement are prominent symptoms. Other less prominent symptoms may include stiffness, redness, swelling and fatigue. A chief factor in the development of this form of arthritis is poor circulation to the microscopic blood vessels that carry oxygen and other nutrients to the joints. The standard American diet creates fatty streaks and plaques to occur in the blood vessels. This diminishes the diameter of the vessel. The aggregation (sticking together) of red blood cells following a fatty meal impedes blood flow and decreases oxygenation of the joints.
The main pathological features of OA include injury and loss of the articular cartilage. These alter the shape of the articular surfaces. The earliest gross changes are softening of the joints and/or stiffness of the articular cartilage. This is brought about by unmasking and fragmentation of the collagen fibril structure of the cartilage. This change is called cartilage fibrillation. Microscopically, the fibrillated cartilage shows clefts or fissures which begin in the superficial layers. They then deepen as the cartilage is eroded and worn away from the surface by tangential flaking, pitting and grooving.
Reduced oxygenation of the joints interferes with the normal repair and remodeling of bone that is ongoing throughout life. In this environment of nutritional inadequacy, tiny structural imperfections that have developed progress to a state of chronic degeneration.
LPG® has a 25-year reputation in the treatment of connective tissue disorders. It has become a leader in the field of natural and non-invasive treatments which is validated by more than 80 studies and 200 scientific publications.
LPG® was founded in the mid 1980’s by Louis Paul Guitay in France. Mr. Guitay invented a method of treatment to help rehabilitate damaged muscle tissue as well as to treat burns and scars. His objective was to standardize physical therapy by providing precisely calibrated and consistent treatment through massage. It has since evolved to include treatments in wellness, beauty and sport.
This natural, non-invasive approach is accomplished with an LPG® Cellu M6i which is classed as an 11a medical device controlled by the A.F.S.SaP.S (French Agency for the Safety of Health Products.) LPG® Endermologie™ carries the CE mark which is the manufacturer’s declaration that the product meets the requirements of the applicable EC directives. It is a mandatory conformity marking within the European Economic Area and it is recognized by Health Canada, license no. 75865.
The Cellu M6i works by applying a gentle negative pressure which creates a fold in the skin and mobilizes it through two motorized rollers.
The patented technique is applied according to specific therapeutic protocols and is performed by a healthcare professional to address pathologies of the connective tissues resulting from disease, trauma, surgery or disabilities.
Areas of application include medical, surgical and sports orientations and its therapeutic values are backed by over 110 scientific studies and 100 publications. This information can be accessed through www.cosire-lpg.com.
Physiological Effects of Endermologie™
The mechanism of action was scientifically studied at UCLA School of Medicine using both human and animal subjects. The SUS scorfa swine model was studied by using subcutaneous endoscopy, photography, gross tissue examination and histological examination. The human subjects were studied by using lymphoscintigraphy, skin perfusion venous color-flow Doppler ultrasonography and laser Doppler blood flow analysis of skin perfusion.
Laser Doppler measurements showed a 4-fold increase in cutaneous blood flow. This increase peaked 10 mins post treatment and lasted for more than 6 hours.
Color-flow Doppler measurements showed increases in the flow velocities of the subcutaneous veins within the adipose tissue and a concomitant decrease in flow velocities of the deep muscular veins.
The conclusion in this study was that, Endermologie™ produces a profound physiological alteration in cutaneous perfusion, subcutaneous perfusion and lymphatic flow. This effect seems to be delayed and prolonged lasting for hours after completion of the treatment.
- Over 5,000 partners worldwide.
- 75,000 equipped centers in the world
- More than 5,000 professionals around the world trained on LPG® techniques each year.
- 200,000 people around the world benefit from LPG® technology every day.
- More than 110 scientific studies.
- More than 50 publications, including 27 indexed on Medline.
- An independent international research committee (COSIRE).
Copyright © 2016 The Coliseum MediClinic Inc. All rights reserved